These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24507794)

  • 1. Biomarkers for cholesterol absorption and synthesis in hyperlipidemic patients: role for therapeutic selection.
    Wu AH
    Clin Lab Med; 2014 Mar; 34(1):157-66, viii. PubMed ID: 24507794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
    Márk L; Paragh G
    Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption.
    Guardamagna O; Abello F; Baracco V; Federici G; Bertucci P; Mozzi A; Mannucci L; Gnasso A; Cortese C
    Acta Diabetol; 2011 Jun; 48(2):127-33. PubMed ID: 21057823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological variation of β-sitosterol, campesterol, and lathosterol as cholesterol absorption and synthesis biomarkers.
    Wu AH; Ruan W; Todd J; Lynch KL
    Clin Chim Acta; 2014 Mar; 430():43-7. PubMed ID: 24394292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.
    Hedman M; Miettinen TA; Gylling H; Ketomäki A; Antikainen M
    J Pediatr; 2006 Feb; 148(2):241-6. PubMed ID: 16492436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
    Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study.
    Miettinen TA; Hallikainen M; Raitakari OT; Viikari J; Gylling H
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):525-31. PubMed ID: 19185477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein.
    Barbosa SP; Lins LC; Fonseca FA; Matos LN; Aguirre AC; Bianco HT; Amaral JB; França CN; Santana JM; Izar MC
    Life Sci; 2013 May; 92(14-16):845-51. PubMed ID: 23507424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia.
    Li ZZ; Huang Q; Yang XL; Zeng J; Wang QH; Tang HM; Yu ZQ; Song YQ; Liu Y
    Dis Markers; 2022; 2022():2008556. PubMed ID: 35493299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan.
    Inoue T; Taguchi I; Abe S; Toyoda S; Sakuma M; Node K
    J Clin Pharm Ther; 2011 Feb; 36(1):103-10. PubMed ID: 21198725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins.
    Miettinen TA; Gylling H; Lindbohm N; Miettinen TE; Rajaratnam RA; Relas H;
    J Lab Clin Med; 2003 Feb; 141(2):131-7. PubMed ID: 12577049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperlipidemia: therapeutic principles in clinical practice].
    Müller-Wieland D; Krone W
    Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in cholesterol absorption and synthesis markers in patients with coronary heart disease after combination therapy with simvastatin plus ezetimibe.
    Zhang T; Wu WF; Liu Y; Wang QH; Wang LY; Mi SH
    Chin Med J (Engl); 2013; 126(9):1618-23. PubMed ID: 23652039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men.
    Nissinen MJ; Miettinen TE; Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):308-16. PubMed ID: 19695854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol absorption inhibition: a strategy for cholesterol-lowering therapy.
    Miettinen TA
    Int J Clin Pract; 2001 Dec; 55(10):710-6. PubMed ID: 11777299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel therapeutic approach to dyslipidemia.
    Clearfield MB
    J Am Osteopath Assoc; 2003 Jan; 103(1 Suppl 1):S16-20. PubMed ID: 12572626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol metabolism differs after statin therapy according to the type of hyperlipemia.
    Lupattelli G; Siepi D; De Vuono S; Roscini AR; Crisanti F; Covelli D; Pirro M; Mannarino E
    Life Sci; 2012 Jun; 90(21-22):846-50. PubMed ID: 22554491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal sterol transporters and cholesterol absorption inhibition.
    Davis HR; Tershakovec AM; Tomassini JE; Musliner T
    Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.